Academic Journal

Benefit from dose-dense adjuvant chemotherapy for breast cancer: subgroup analyses from the randomised phase 3 PANTHER trial.

التفاصيل البيبلوغرافية
العنوان: Benefit from dose-dense adjuvant chemotherapy for breast cancer: subgroup analyses from the randomised phase 3 PANTHER trial.
المؤلفون: Matikas, Alexios, Papakonstantinou, Andri, Loibl, Sibylle, Steger, Günther G, Untch, Michael, Johansson, Hemming, Tsiknakis, Nikos, Hellström, Mats, Greil, Richard, Möbus, Volker, Gnant, Michael, Bergh, Jonas, Foukakis, Theodoros
المصدر: Lancet Reg Health Eur ; ISSN:2666-7762 ; Volume:49
بيانات النشر: PubMed Central
سنة النشر: 2025
المجموعة: PubMed Central (PMC)
مصطلحات موضوعية: Adjuvant chemotherapy, Amenorrhea, Breast cancer, Dose-dense, PREDICT, STEPP
الوصف: It is unclear whether some patients with high-risk breast cancer do not warrant adjuvant dose-dense chemotherapy due to small expected absolute benefit.
نوع الوثيقة: article in journal/newspaper
اللغة: English
Relation: https://doi.org/10.1016/j.lanepe.2024.101162; https://pubmed.ncbi.nlm.nih.gov/39703564; https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11652897/
DOI: 10.1016/j.lanepe.2024.101162
الاتاحة: https://doi.org/10.1016/j.lanepe.2024.101162
https://pubmed.ncbi.nlm.nih.gov/39703564
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11652897/
Rights: © 2024 The Author(s).
رقم الانضمام: edsbas.24A1116
قاعدة البيانات: BASE
الوصف
DOI:10.1016/j.lanepe.2024.101162